Prostate Cancer Management Masterclass: mCSPC Plenary Session 1
Prostate Cancer Management Masterclass: mCSPC Plenary Session 1
Dr. Neal D. Shore, Assoc. Prof. Alicia Morgans
Dr. Neal Shore and Assoc. Prof. Alicia Morgans present a plenary on the paradigm shift in the management of metastatic castration-sensitive prostate cancer (mCSPC).Dr. Neal D. Shore
Urologist
Carolina Urologic Research Centre and GenesisCare
United States (US)
Dr. Neal D. Shore has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Assoc. Prof. Alicia Morgans
Medical Oncologist
Dana-Farber Cancer Institute
United States (US)
Assoc. Prof. Alicia Morgans has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Webinar | 35 min | Dec 2020
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
Prostate Cancer Management Masterclass: mCSPC Plenary Session 1
Prof. Alicia Morgans, co-hosted, along with Dr. Neal Shore, Prof. Tanya Dorff and Prof. Evan Yu, a highly interactive GU CONNECT Virtual Masterclass on Prostate Cancer Management.
In this first plenary Dr. Neal Shore and Prof. Alicia Morgans, present a Paradigm shift in the management of metastatic castration-sensitive prostate cancer (mCSPC).
In plenary 2 Prof. Tanya Dorff and Prof. Evan Yu present “Next-generation” sequencing of therapy for Castration-Resistant Prostate Cancer (CRPC).
Watch the video and download the slides.
GU CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from AstraZeneca, Bayer and Eisai Europe Limited.